Literature DB >> 673773

[Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].

A Buge, M Poisson, S Masson, J M Bleibel, B Lafforgue, P Raymond, M C Jaudon.   

Abstract

A case of encephalopathy with elevation of plasma aluminium level in a patient treated by maintenance hemodialysis is reported. Clinical symptoms were made of moderate impairment of intellectual functions and of intermittent drowsiness. EEG after 3 minutes of hyperpnea evidenced bisynchronous anteriorly dominant intermittent delta waves. Plasma aluminium level, determined by atomic absorption spectrophotometry, was initially at 300 microgram/l (normal range greater than 40 microgram/l). After interruption of aluminium gels, clinical and EEG symptoms slowly subsided in 9 months, plasma aluminium level came down to 145 microgram/l. This picture of encephalopathy could preceede irreversible dialysis dementia in chronic dialysis patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 673773

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  4 in total

1.  Multiorgan aluminium deposits in a chronic haemodialysis patient. Electron microscope and microprobe studies.

Authors:  A Roth; C Nogues; P Galle; T Drüeke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

2.  Dialysis encephalopathy: recovery after interruption of aluminium intake.

Authors:  M Poisson; R Mashaly; B Lebkiri
Journal:  Br Med J       Date:  1978-12-09

3.  Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre: evidence for "safe" upper limit of aluminium in water.

Authors:  M M Platts; G Owen; S Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-31

4.  Epileptic phenomena in bismuth toxic encephalopathy.

Authors:  A Buge; V Supino-Viterbo; G Rancurel; C Pontes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.